Overview

Exercise Induced Bronchospasm in Children

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to test how well 2 different medications stop asthma symptoms caused by exercising. The two medications that will be tested are "pretreatment with albuterol" and montelukast (Singulair®). Although both medications are used for treating asthma, we don't know which medicine is better at stopping asthma symptoms caused by exercising.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of New Mexico
Collaborator:
American College of Clinical Pharmacy
Treatments:
Albuterol
Montelukast
Criteria
Inclusion Criteria:

- Children 7-17 years of age

- Physician diagnosed asthma for at least 6 months

- EIB diagnosed by a positive exercise challenge at screening and baseline visits

- Forced expiratory volume in 1 second (FEV1) ≥ 70% of predicted at screening and
baseline visit

Exclusion Criteria:

- History of cardiac dysfunction

- Unable to perform exercise challenge

- Use of montelukast